Skip to main content

Table 1 Baseline patient characteristics

From: Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer

Variable
N= 112
Median ± SE Number
(%)
Age (years) 50 ± 11  
Tumor size
(cm)
5 ± 1.56
Mean, 3.93
 
Clinical T stage*   
   T2   22 (19.6)
   T3   50 (44.6)
   T4   40 (35.7)
Clinical N stage*   
   N1   55 (49.1)
   N2   56 (50)
   N3   1 (0.9)
Clinical stage*   
   IIB   24 (21.4)
   IIIA   48 (42.9)
   IIIB   40 (35.7)
Histological grade†   
   Low/moderate   45 (40.2)
   High   67 (59.8)
Estrogen receptors   
   Positive   48 (42.9)
   Negative   64 (57.1)
Progesterone receptors   
   Positive   46 (41.1)
   Negative   66 (58.9)
Treatment after CCRTh   
   Anthracycline   54 (48.2)
   Taxanes   58 (51.8)
  1. Abbreviations: SE = standard error; CCRTh = concurrent chemo-radiotherapy.
  2. * 6th edition of the American Joint Committee on Cancer TNM classification
  3. and staging system.
  4. † Scarff-Bloom-Richardson (SBR) scale.